BARCLAYS PLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 26 filers reported holding SEELOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$13,000
-96.7%
15,948
-93.3%
0.00%
Q4 2021$390,000
+302.1%
238,478
+494.0%
0.00%
Q3 2021$97,000
-38.2%
40,146
-32.6%
0.00%
Q2 2021$157,000
+3040.0%
59,608
+5860.8%
0.00%
Q1 2021$5,0001,000
+273.1%
0.00%
Q2 2020$0268
+26700.0%
0.00%
Q4 2019$010.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,908,725$5,056,0000.66%
Uniplan Investment Counsel, Inc. 2,485,327$2,559,0000.20%
Oasis Management Co Ltd. 850,000$876,0000.15%
AdvisorShares Investments LLC 470,151$484,0000.13%
1492 Capital Management LLC 99,819$103,0000.07%
Sovereign Financial Group, Inc. 75,000$77,0000.03%
ASSET MANAGEMENT CORP /IL/ /ADV 45,500$47,0000.03%
MAI Capital Management 1,230,810$1,268,0000.02%
GSA CAPITAL PARTNERS LLP 137,266$141,0000.02%
FORTEM FINANCIAL GROUP, LLC 20,000$21,0000.02%
View complete list of SEELOS THERAPEUTICS INC shareholders